Drug profile · INN
fenoldopam mesylate
FENOLDOPAM MESYLATE
fenoldopam mesylate (FENOLDOPAM MESYLATE) is a dopamine d1 receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — fenoldopam mesylate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
fenoldopam mesylate (FENOLDOPAM MESYLATE) is a dopamine d1 receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D1 receptor agonist
Primary target: D(1A) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fenoldopam mesylate?
fenoldopam mesylate (FENOLDOPAM MESYLATE) is a dopamine d1 receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for fenoldopam mesylate?
FENOLDOPAM MESYLATE is a marketed brand name for fenoldopam mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fenoldopam mesylate?
fenoldopam mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.